1. Home
  2. VALN vs CFFN Comparison

VALN vs CFFN Comparison

Compare VALN & CFFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • CFFN
  • Stock Information
  • Founded
  • VALN 2012
  • CFFN 1893
  • Country
  • VALN France
  • CFFN United States
  • Employees
  • VALN N/A
  • CFFN N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • CFFN Savings Institutions
  • Sector
  • VALN Health Care
  • CFFN Finance
  • Exchange
  • VALN Nasdaq
  • CFFN Nasdaq
  • Market Cap
  • VALN 989.8M
  • CFFN 813.3M
  • IPO Year
  • VALN 2021
  • CFFN 1999
  • Fundamental
  • Price
  • VALN $8.63
  • CFFN $6.42
  • Analyst Decision
  • VALN Strong Buy
  • CFFN Hold
  • Analyst Count
  • VALN 4
  • CFFN 1
  • Target Price
  • VALN $16.00
  • CFFN $6.50
  • AVG Volume (30 Days)
  • VALN 153.6K
  • CFFN 604.7K
  • Earning Date
  • VALN 08-12-2025
  • CFFN 10-22-2025
  • Dividend Yield
  • VALN N/A
  • CFFN 5.25%
  • EPS Growth
  • VALN N/A
  • CFFN N/A
  • EPS
  • VALN N/A
  • CFFN 0.47
  • Revenue
  • VALN $230,566,060.00
  • CFFN $192,483,000.00
  • Revenue This Year
  • VALN $15.55
  • CFFN $10.56
  • Revenue Next Year
  • VALN $23.93
  • CFFN $11.73
  • P/E Ratio
  • VALN N/A
  • CFFN $13.78
  • Revenue Growth
  • VALN 25.47
  • CFFN N/A
  • 52 Week Low
  • VALN $3.62
  • CFFN $4.90
  • 52 Week High
  • VALN $12.25
  • CFFN $7.20
  • Technical
  • Relative Strength Index (RSI)
  • VALN 46.03
  • CFFN 62.24
  • Support Level
  • VALN $8.71
  • CFFN $6.02
  • Resistance Level
  • VALN $9.05
  • CFFN $6.53
  • Average True Range (ATR)
  • VALN 0.46
  • CFFN 0.11
  • MACD
  • VALN -0.38
  • CFFN 0.04
  • Stochastic Oscillator
  • VALN 13.63
  • CFFN 78.43

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About CFFN Capitol Federal Financial Inc.

Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank, Capitol Federal Savings Bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It primarily serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.

Share on Social Networks: